[1]Nakamura S, Ponzoni M, Campo E. Intravascular large B-cell lymphoma. In : Swerlow SH, Campo E, Harris NL, et al, eds. WHO classification of tumors oh hematopoietic and lymphoid tissues. Lyon : IARC Press, 2017: pp 317-20.
[2]Shimada K., Kinoshita T., Naoe T., Nakamura S. Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol. 2009;10:895-902.
[3]Shimada K, Yamaguchi M, Atsuta Y and al. Rituximab, cyclophosphamide, doxorubicine, vincristine, and prednisolone combined with high-dose méthotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL) : a multicentre, single arm, phase 2 trial. The lancet 21 April 2020.